Contemporary HIV Treatment and Prevention 2022: Barriers and Solutions to Expanding PrEP Uptake – Pharmacist Perspectives

Read expert faculty members’ summaries of barriers and solutions to PrEP uptake in key populations including, adolescents, Black and Hispanic/Latinx people, cisgender women, transgender women, and people who inject drugs.
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Format: Microsoft PowerPoint (.ppt)
File Size: 865 KB
Released: May 31, 2022

Acknowledgements

Jointly provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Related Content

Clinical Care Options (CCO) presents patient advocate and patient discussing the importance of overcoming local barriers to HIV care for women

person default Angelina Namiba Released: August 5, 2022

Safety and efficacy of broadly neutralizing antibody VRC01 with early ART in infants with HIV, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 5, 2022

HIV self-testing and 6-month PrEP dispensing simplified PrEP delivery with no reduction in HIV testing or PrEP adherence, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 5, 2022

Safety and efficacy of 24-wk oral regimens for pulmonary rifampicin-resistant TB in persons with HIV, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 4, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings